Wave Life Sciences CFO Sells Shares Under Trading Plan
| Reporter Name | Moran Kyle |
| Relationship | Chief Financial Officer |
| Type | Sell |
| Amount | $154,314 |
| SEC Filing | Form 4 |
Wave Life Sciences Ltd. Chief Financial Officer, Kyle Moran, sold 17,146 ordinary shares on September 25, 2024, at a price of $9.0 per share, totaling $154,314. The sale was conducted under a Rule 10b5-1 trading plan adopted on November 21, 2023. Following the transaction, Moran directly owns 19,777 ordinary shares of the company. This ownership includes 3,002 shares acquired on July 14, 2024, under the company's 2019 Employee Share Purchase Plan.
SEC Filing: Wave Life Sciences Ltd. [ WVE ] - Form 4 - Sep. 27, 2024